Yumanity Therapeutics announced the appointment of Devin W. Smith as Senior Vice President and General Counsel. Mr. Smith is an attorney highly experienced in providing legal advice to biopharmaceutical companies. Most recently, he served as Senior Vice President and General Counsel for publicly traded Minerva Neurosciences, where he provided strategic legal advice and was responsible for corporate governance and SEC compliance. Prior to that, Mr. Smith was General Counsel and Corporate Secretary for the publicly traded immunology company Stallergenes Greer PLC. Before joining Stallergenes Greer, Mr. Smith served as Associate General Counsel and Vice President and General Counsel at EMD Serono, Inc.